Medicine's Jonathan Haines discusses his research on Alzheimer’s genetic targets

CWRU receives $6.2M to identify Alzheimer’s genetic targets

cleveland.com: Jonathan Haines, principal investigator and chair of the Department of Population and Quantitative Health Sciences, said his recent research aims to provide doctors and drugmakers with new information that could prevent, slow or even cure the disease. “We plan to harness the power of massive whole-genome datasets from two of the most comprehensive Alzheimer’s genetic research initiatives in the world,” Haines said.